These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 9108670)

  • 41. Growth hormone secretagogues: mechanism of action and use in aging.
    Fuh VL; Bach MA
    Growth Horm IGF Res; 1998 Feb; 8(1):13-20. PubMed ID: 10990440
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Treatment of obese subjects with the oral growth hormone secretagogue MK-677 affects serum concentrations of several lipoproteins, but not lipoprotein(a).
    Svensson J; Jansson JO; Ottosson M; Johannsson G; Taskinen MR; Wiklund O; Bengtsson BA
    J Clin Endocrinol Metab; 1999 Jun; 84(6):2028-33. PubMed ID: 10372705
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Polysomnographic sleep, growth hormone insulin-like growth factor-I axis, leptin, and weight loss.
    Rasmussen MH; Wildschiødtz G; Juul A; Hilsted J
    Obesity (Silver Spring); 2008 Jul; 16(7):1516-21. PubMed ID: 18464752
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Tripartite neuroendocrine activation of the human growth hormone (GH) axis in women by continuous 24-hour GH-releasing peptide infusion: pulsatile, entropic, and nyctohemeral mechanisms.
    Shah N; Evans WS; Bowers CY; Veldhuis JD
    J Clin Endocrinol Metab; 1999 Jun; 84(6):2140-50. PubMed ID: 10372723
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Increased orderliness of growth hormone (GH) secretion in GH-deficient adults with low serum insulin-like growth factor I.
    Svensson J; Veldhuis JD; Iranmanesh A; Bengtsson BA; Johannsson G
    J Clin Endocrinol Metab; 2002 Jun; 87(6):2863-9. PubMed ID: 12050264
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The somatopause: should growth hormone deficiency in older people Be treated?
    Lieberman SA; Hoffman AR
    Clin Geriatr Med; 1997 Nov; 13(4):671-84. PubMed ID: 9354748
    [TBL] [Abstract][Full Text] [Related]  

  • 47. IGF-1 levels in different conditions of low somatotrope secretion in adulthood: obesity in comparison with GH deficiency.
    Maccario M; Grottoli S; Aimaretti G; Gianotti L; Endrio Oleandri S; Procopio M; Savio P; Tassone F; Ramunni J; Camanni F; Ghigo E
    Minerva Endocrinol; 1999 Jun; 24(2):57-61. PubMed ID: 10941424
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Diagnosis of growth hormone (GH) deficiency in adults with hypothalamic-pituitary disorders: comparison of test results using pyridostigmine plus GH-releasing hormone (GHRH), clonidine plus GHRH, and insulin-induced hypoglycemia as GH secretagogues.
    Hoeck HC; Vestergaard P; Jakobsen PE; Falhof J; Laurberg P
    J Clin Endocrinol Metab; 2000 Apr; 85(4):1467-72. PubMed ID: 10770183
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The effects of growth hormone and insulin-like growth factor-1 on the aging cardiovascular system and its progenitor cells.
    Devin JK; Young PP
    Curr Opin Investig Drugs; 2008 Sep; 9(9):983-92. PubMed ID: 18729005
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Insulin-like Growth Factor I and its binding protein 3 in sepsis.
    Papastathi C; Mavrommatis A; Mentzelopoulos S; Konstandelou E; Alevizaki M; Zakynthinos S
    Growth Horm IGF Res; 2013 Aug; 23(4):98-104. PubMed ID: 23611528
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prolactin deficiency is independently associated with reduced insulin-like growth factor I status in severely growth hormone-deficient adults.
    Mukherjee A; Ryder WD; Jöstel A; Shalet SM
    J Clin Endocrinol Metab; 2006 Jul; 91(7):2520-5. PubMed ID: 16621908
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prolonged oral treatment with MK-677, a novel growth hormone secretagogue, improves sleep quality in man.
    Copinschi G; Leproult R; Van Onderbergen A; Caufriez A; Cole KY; Schilling LM; Mendel CM; De Lepeleire I; Bolognese JA; Van Cauter E
    Neuroendocrinology; 1997 Oct; 66(4):278-86. PubMed ID: 9349662
    [TBL] [Abstract][Full Text] [Related]  

  • 53. WINNERS OF THE THEODORE E. WOODWARD AWARD.
    Trans Am Clin Climatol Assoc; 2022; 132():105-106. PubMed ID: 36196163
    [No Abstract]   [Full Text] [Related]  

  • 54. Use of growth hormone secretagogues to prevent or treat the effects of aging: not yet ready for prime time.
    Blackman MR
    Ann Intern Med; 2008 Nov; 149(9):677-9. PubMed ID: 18981489
    [No Abstract]   [Full Text] [Related]  

  • 55. Theodore E. Woodward Award. Ischemic heart disease in women: the role of coronary microvascular dysfunction.
    Pepine CJ
    Trans Am Clin Climatol Assoc; 1999; 110():107-16; discussion 117-8. PubMed ID: 10344011
    [No Abstract]   [Full Text] [Related]  

  • 56. Orally active growth hormone secretagogues.
    Patchett AA; Smith RG; Wyvratt MJ
    Pharm Biotechnol; 1998; 11():525-54. PubMed ID: 9760695
    [No Abstract]   [Full Text] [Related]  

  • 57. Sarcopenia and the elusive fountain of youth.
    Hanauer SB
    Nat Clin Pract Gastroenterol Hepatol; 2009 Jan; 6(1):1. PubMed ID: 19127276
    [No Abstract]   [Full Text] [Related]  

  • 58. THE THEODORE E. WOODWARD AWARD.
    Trans Am Clin Climatol Assoc; 2022; 132():104. PubMed ID: 36196191
    [No Abstract]   [Full Text] [Related]  

  • 59. Award Winner's Lecture. A touch of growth.
    Rappaport R
    Horm Res; 1991; 36(5-6):166-73. PubMed ID: 1823074
    [No Abstract]   [Full Text] [Related]  

  • 60. Growth hormone secretagogues as therapeutic agents.
    Svensson J
    Growth Horm IGF Res; 1999 Apr; 9 Suppl A():107-9. PubMed ID: 10429892
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.